Skip to main content
Top
Published in: Journal of General Internal Medicine 1/2008

Open Access 01-01-2008 | Original Article

Cardiac Device Implantation in the United States from 1997 through 2004: A Population-based Analysis

Authors: Chunliu Zhan, MD, PhD, William B. Baine, MD, Artyom Sedrakyan, MD, PhD, Claudia Steiner, MPH, MD

Published in: Journal of General Internal Medicine | Special Issue 1/2008

Login to get access

Abstract

OBJECTIVE

Use of cardiac devices has been increasing rapidly along with concerns over their safety and effectiveness. This study used hospital administrative data to assess cardiac device implantations in the United States, selected perioperative outcomes, and associated patient and hospital characteristics.

METHODS

We screened hospital discharge abstracts from the 1997–2004 Healthcare Cost and Utilization Project Nationwide Inpatient Samples. Patients who underwent implantation of pacemaker (PM), automatic cardioverter/defibrillator (AICD), or cardiac resynchronization therapy pacemaker (CRT-P) or defibrillator (CRT-D) were identified using ICD-9-CM procedure codes. Outcomes ascertainable from these data and associated hospital and patient characteristics were analyzed.

MEASUREMENTS AND MAIN RESULTS

Approximately 67,000 AICDs and 178,000 PMs were implanted in 2004 in the United States, increasing 60% and 19%, respectively, since 1997. After FDA approval in 2001, CRT-D and CRT-P reached 33,000 and 7,000 units per year in the United States in 2004. About 70% of the patients were aged 65 years or older, and more than 75% of the patients had 1 or more comorbid diseases. There were substantial decreases in length of stay, but marked increases in charges, for example, the length of stay of AICD implantations halved (from 9.9 days in 1997 to 5.2 days in 2004), whereas charges nearly doubled (from $66,000 in 1997 to $117,000 in 2004). Rates of in-hospital mortality and complications fluctuated slightly during the period. Overall, adverse outcomes were associated with advanced age, comorbid conditions, and emergency admissions, and there was no consistent volume–outcome relationship across different outcome measures and patient groups.

CONCLUSIONS

The numbers of cardiac device implantations in the United States steadily increased from 1997 to 2004, with substantial reductions in length of stay and increases in charges. Rates of in-hospital mortality and complications changed slightly over the years and were associated primarily with patient frailty.
Appendix
Available only for authorised users
Literature
1.
go back to reference Maisel WH. Cardiovascular device development: lessons learned from pacemaker and implantable cardioverter-defibrillator therapy. Am J Ther. 2005;12(2):183–5.PubMedCrossRef Maisel WH. Cardiovascular device development: lessons learned from pacemaker and implantable cardioverter-defibrillator therapy. Am J Ther. 2005;12(2):183–5.PubMedCrossRef
2.
go back to reference Pavia S, Wilkoff B. The management of surgical complications of pacemaker and implantable cardioverter-defibrillators. Curr Opin Cardiol. 2001;16(1):66–71.PubMedCrossRef Pavia S, Wilkoff B. The management of surgical complications of pacemaker and implantable cardioverter-defibrillators. Curr Opin Cardiol. 2001;16(1):66–71.PubMedCrossRef
3.
go back to reference Goldberger Z, Lampert R. Implantable cardioverter-defibrillators: expanding indications and technologies. JAMA. 2006;295(7):809–18.PubMedCrossRef Goldberger Z, Lampert R. Implantable cardioverter-defibrillators: expanding indications and technologies. JAMA. 2006;295(7):809–18.PubMedCrossRef
4.
go back to reference Bernstein AD, Parsonnet V. Survey of cardiac pacing and defibrillation in the United States in 1993. Am J Cardiol. 1996;78(2):187–96.PubMedCrossRef Bernstein AD, Parsonnet V. Survey of cardiac pacing and defibrillation in the United States in 1993. Am J Cardiol. 1996;78(2):187–96.PubMedCrossRef
5.
go back to reference Bernstein AD, Parsonnet V. Survey of cardiac pacing and implanted defibrillator practice patterns in the United States in 1997. Pacing Clin Electrophysiol. 2001;24(5):842–55.PubMedCrossRef Bernstein AD, Parsonnet V. Survey of cardiac pacing and implanted defibrillator practice patterns in the United States in 1997. Pacing Clin Electrophysiol. 2001;24(5):842–55.PubMedCrossRef
6.
go back to reference Daley WR, Kaczmarek RG. The epidemiology of cardiac pacemakers in the older US population. J Am Geriatr Soc. 1998;46(8):1016–9.PubMed Daley WR, Kaczmarek RG. The epidemiology of cardiac pacemakers in the older US population. J Am Geriatr Soc. 1998;46(8):1016–9.PubMed
7.
go back to reference Cabell CH, Heidenreich PA, Chu VH, et al. Increasing rates of cardiac device infections among Medicare beneficiaries: 1990–1999. Am Heart J. 2004;147(4):582–6.PubMedCrossRef Cabell CH, Heidenreich PA, Chu VH, et al. Increasing rates of cardiac device infections among Medicare beneficiaries: 1990–1999. Am Heart J. 2004;147(4):582–6.PubMedCrossRef
8.
go back to reference Maisel WH, American Cardiology C, American Heart A, North American Society of Pacing and Electrophysiology. Impact of expanding indications on the safety of pacemakers and defibrillators. Cardiac Electrophysiology Review. 2003;7(1):30–2.PubMedCrossRef Maisel WH, American Cardiology C, American Heart A, North American Society of Pacing and Electrophysiology. Impact of expanding indications on the safety of pacemakers and defibrillators. Cardiac Electrophysiology Review. 2003;7(1):30–2.PubMedCrossRef
9.
go back to reference Bradley DJ, Bradley EA, Baughman KL, et al. Cardiac resynchronization and death from progressive heart failure: a meta-analysis of randomized controlled trials. JAMA. 2003;289(6):730–40.PubMedCrossRef Bradley DJ, Bradley EA, Baughman KL, et al. Cardiac resynchronization and death from progressive heart failure: a meta-analysis of randomized controlled trials. JAMA. 2003;289(6):730–40.PubMedCrossRef
10.
go back to reference Bax JJ, Abraham T, Barold SS, et al. Cardiac resynchronization therapy. Part 2: Issues during and after device implantation and unresolved questions. J Am Coll Cardiol. 2005;46(12):2168–82.PubMedCrossRef Bax JJ, Abraham T, Barold SS, et al. Cardiac resynchronization therapy. Part 2: Issues during and after device implantation and unresolved questions. J Am Coll Cardiol. 2005;46(12):2168–82.PubMedCrossRef
11.
go back to reference Leon AR, Abraham WT, Curtis AB, et al. Safety of transvenous cardiac resynchronization system implantation in patients with chronic heart failure: combined results of over 2,000 patients from a multicenter study program. J Am Coll Cardiol. 2005;46(12):2348–56.PubMedCrossRef Leon AR, Abraham WT, Curtis AB, et al. Safety of transvenous cardiac resynchronization system implantation in patients with chronic heart failure: combined results of over 2,000 patients from a multicenter study program. J Am Coll Cardiol. 2005;46(12):2348–56.PubMedCrossRef
12.
go back to reference Cleland JG, Daubert JC, Erdmann E, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005;352(15):1539–49.PubMedCrossRef Cleland JG, Daubert JC, Erdmann E, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005;352(15):1539–49.PubMedCrossRef
13.
go back to reference Young JB, Abraham WT, Smith AL, et al. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. JAMA. 2003;289(20):2685–94.PubMedCrossRef Young JB, Abraham WT, Smith AL, et al. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. JAMA. 2003;289(20):2685–94.PubMedCrossRef
14.
go back to reference Wiegand UK, Bode F, Bonnemeier H, Eberhard F, Schlei M, Peters W. Long-term complication rates in ventricular, single lead VDD, and dual chamber pacing. Pacing Clin Electrophysiol. 2003;26(10):1961–9.PubMedCrossRef Wiegand UK, Bode F, Bonnemeier H, Eberhard F, Schlei M, Peters W. Long-term complication rates in ventricular, single lead VDD, and dual chamber pacing. Pacing Clin Electrophysiol. 2003;26(10):1961–9.PubMedCrossRef
15.
go back to reference Wiegand UK, LeJeune D, Boguschewski F, et al. Pocket hematoma after pacemaker or implantable cardioverter defibrillator surgery: influence of patient morbidity, operation strategy, and perioperative antiplatelet/anticoagulation therapy. Chest. 2004;126(4):1177–86.PubMedCrossRef Wiegand UK, LeJeune D, Boguschewski F, et al. Pocket hematoma after pacemaker or implantable cardioverter defibrillator surgery: influence of patient morbidity, operation strategy, and perioperative antiplatelet/anticoagulation therapy. Chest. 2004;126(4):1177–86.PubMedCrossRef
16.
go back to reference Rozmus G, Daubert JP, Huang DT, Rosero S, Hall B, Francis C. Venous thrombosis and stenosis after implantation of pacemakers and defibrillators. Journal Interventional Cardiac Electrophysiology. 2005;13(1):9–19.CrossRef Rozmus G, Daubert JP, Huang DT, Rosero S, Hall B, Francis C. Venous thrombosis and stenosis after implantation of pacemakers and defibrillators. Journal Interventional Cardiac Electrophysiology. 2005;13(1):9–19.CrossRef
17.
go back to reference Tri JL, Trusty JM, Hayes DL. Potential for Personal Digital Assistant interference with implantable cardiac devices. Mayo Clin Proc. 2004;79(12):1527–30.PubMed Tri JL, Trusty JM, Hayes DL. Potential for Personal Digital Assistant interference with implantable cardiac devices. Mayo Clin Proc. 2004;79(12):1527–30.PubMed
18.
go back to reference Sweeney MO, Shea JB, Ellison KE. Upgrade of permanent pacemakers and single chamber implantable cardioverter defibrillators to pectoral dual chamber implantable cardioverter defibrillators: indications, surgical approach, and long-term clinical results. Pacing Clin Electrophysiol. 2002;25(12):1715–23.PubMedCrossRef Sweeney MO, Shea JB, Ellison KE. Upgrade of permanent pacemakers and single chamber implantable cardioverter defibrillators to pectoral dual chamber implantable cardioverter defibrillators: indications, surgical approach, and long-term clinical results. Pacing Clin Electrophysiol. 2002;25(12):1715–23.PubMedCrossRef
19.
go back to reference Maisel WH. Pacemaker and ICD generator reliability: meta-analysis of device registries. JAMA. 2006;295(16):1929–34.PubMedCrossRef Maisel WH. Pacemaker and ICD generator reliability: meta-analysis of device registries. JAMA. 2006;295(16):1929–34.PubMedCrossRef
20.
go back to reference Hammill S, Phurrough S, Brindis R. The national ICD registry: now and into the future. Heart Rhythm. 2006;3(4):470–3.PubMedCrossRef Hammill S, Phurrough S, Brindis R. The national ICD registry: now and into the future. Heart Rhythm. 2006;3(4):470–3.PubMedCrossRef
22.
go back to reference Maisel WH, Moynahan M, Zuckerman BD, et al. Pacemaker and ICD generator malfunctions: analysis of Food and Drug Administration annual reports. JAMA. 2006;295(16):1901–6.PubMedCrossRef Maisel WH, Moynahan M, Zuckerman BD, et al. Pacemaker and ICD generator malfunctions: analysis of Food and Drug Administration annual reports. JAMA. 2006;295(16):1901–6.PubMedCrossRef
23.
24.
go back to reference Gould PA, Krahn AD. Complications associated with implantable cardioverter-defibrillator replacement in response to device advisories. JAMA. 2006;295(16):1907–11.PubMedCrossRef Gould PA, Krahn AD. Complications associated with implantable cardioverter-defibrillator replacement in response to device advisories. JAMA. 2006;295(16):1907–11.PubMedCrossRef
25.
go back to reference Maisel WH, Stevenson WG, Epstein LM. Changing trends in pacemaker and implantable cardioverter defibrillator generator advisories. Pacing Clin Electrophysiol. 2002;25(12):1670–8.PubMedCrossRef Maisel WH, Stevenson WG, Epstein LM. Changing trends in pacemaker and implantable cardioverter defibrillator generator advisories. Pacing Clin Electrophysiol. 2002;25(12):1670–8.PubMedCrossRef
26.
go back to reference Maisel WH, Sweeney MO, Stevenson WG, Ellison KE, Epstein LM. Recalls and safety alerts involving pacemakers and implantable cardioverter-defibrillator generators. [See comment]. JAMA. 2001;286(7):793–99.PubMedCrossRef Maisel WH, Sweeney MO, Stevenson WG, Ellison KE, Epstein LM. Recalls and safety alerts involving pacemakers and implantable cardioverter-defibrillator generators. [See comment]. JAMA. 2001;286(7):793–99.PubMedCrossRef
27.
go back to reference Bernstein AD, Parsonnet V. Survey of cardiac pacing in the United States in 1989. Am J Cardiol. 1992;69(4):331–8.PubMedCrossRef Bernstein AD, Parsonnet V. Survey of cardiac pacing in the United States in 1989. Am J Cardiol. 1992;69(4):331–8.PubMedCrossRef
28.
go back to reference Mond HG, Irwin M, Morillo C, Ector H. The world survey of cardiac pacing and cardioverter defibrillators: calendar year 2001. Pacing Clin Electrophysiol. 2004;27(7):955–64.PubMedCrossRef Mond HG, Irwin M, Morillo C, Ector H. The world survey of cardiac pacing and cardioverter defibrillators: calendar year 2001. Pacing Clin Electrophysiol. 2004;27(7):955–64.PubMedCrossRef
29.
go back to reference Zhan C, Miller M. Administrative data-based patient safety research: a critical review. Quality and Safety of Health Care. 2003;12(Suppl II):II58–II63. Zhan C, Miller M. Administrative data-based patient safety research: a critical review. Quality and Safety of Health Care. 2003;12(Suppl II):II58–II63.
31.
go back to reference Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998;36(1):8–27.PubMedCrossRef Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998;36(1):8–27.PubMedCrossRef
32.
go back to reference Curtis AB, Ellenbogen KA, Hammill SC, et al. Clinical competency statement: training pathways for implantation of cardioverter defibrillators and cardiac resynchronization devices. [See comment]. Heart Rhythm. 2004;1(3):371–5.PubMedCrossRef Curtis AB, Ellenbogen KA, Hammill SC, et al. Clinical competency statement: training pathways for implantation of cardioverter defibrillators and cardiac resynchronization devices. [See comment]. Heart Rhythm. 2004;1(3):371–5.PubMedCrossRef
33.
go back to reference Tobin K, Stewart J, Westveer D, Frumin H. Acute complications of permanent pacemaker implantation: their financial implication and relation to volume and operator experience. Am J Cardiol. 2000;85(6):774–6.PubMedCrossRef Tobin K, Stewart J, Westveer D, Frumin H. Acute complications of permanent pacemaker implantation: their financial implication and relation to volume and operator experience. Am J Cardiol. 2000;85(6):774–6.PubMedCrossRef
34.
go back to reference Parsonnet V, Bernstein AD, Lindsay B. Pacemaker-implantation complication rates: an analysis of some contributing factors. J Am Coll Cardiol. 1989;13(4):917–21.PubMedCrossRef Parsonnet V, Bernstein AD, Lindsay B. Pacemaker-implantation complication rates: an analysis of some contributing factors. J Am Coll Cardiol. 1989;13(4):917–21.PubMedCrossRef
37.
go back to reference Gupta A, Zegel HG, Dravid VS, Nierenberg SJ, Freiman DB. Value of radiography in diagnosing complications of cardioverter defibrillators implanted without thoracotomy in 437 patients. AJR Am J Roentgenol. 1997;168(1):105–8.PubMed Gupta A, Zegel HG, Dravid VS, Nierenberg SJ, Freiman DB. Value of radiography in diagnosing complications of cardioverter defibrillators implanted without thoracotomy in 437 patients. AJR Am J Roentgenol. 1997;168(1):105–8.PubMed
38.
go back to reference Pfeiffer D, Jung W, Fehske W, et al. Complications of pacemaker-defibrillator devices: diagnosis and management. Am Heart J. 1994;127(4 Pt 2):1073–80.PubMedCrossRef Pfeiffer D, Jung W, Fehske W, et al. Complications of pacemaker-defibrillator devices: diagnosis and management. Am Heart J. 1994;127(4 Pt 2):1073–80.PubMedCrossRef
39.
go back to reference Harcombe AA, Newell SA, Ludman PF, et al. Late complications following permanent pacemaker implantation or elective unit replacement. Heart. 1998;80(3):240–4.PubMed Harcombe AA, Newell SA, Ludman PF, et al. Late complications following permanent pacemaker implantation or elective unit replacement. Heart. 1998;80(3):240–4.PubMed
40.
go back to reference Aggarwal RK, Connelly DT, Ray SG, Ball J, Charles RG. Early complications of permanent pacemaker implantation: no difference between dual and single chamber systems. Br Heart J. 1995;73(6):571–5.PubMedCrossRef Aggarwal RK, Connelly DT, Ray SG, Ball J, Charles RG. Early complications of permanent pacemaker implantation: no difference between dual and single chamber systems. Br Heart J. 1995;73(6):571–5.PubMedCrossRef
41.
go back to reference Jones GK, Bardy GH, Kudenchuk PJ, et al. Mechanical complications after implantation of multiple-lead nonthoracotomy defibrillator systems: implications for management and future system design. Am Heart J. 1995;130(2):327–33.PubMedCrossRef Jones GK, Bardy GH, Kudenchuk PJ, et al. Mechanical complications after implantation of multiple-lead nonthoracotomy defibrillator systems: implications for management and future system design. Am Heart J. 1995;130(2):327–33.PubMedCrossRef
42.
go back to reference Kiviniemi MS, Pirnes MA, Eranen HJ, Kettunen RV, Hartikainen JE. Complications related to permanent pacemaker therapy. Pacing Clin Electrophysiol. 1999;22(5):711–20.PubMedCrossRef Kiviniemi MS, Pirnes MA, Eranen HJ, Kettunen RV, Hartikainen JE. Complications related to permanent pacemaker therapy. Pacing Clin Electrophysiol. 1999;22(5):711–20.PubMedCrossRef
43.
go back to reference Da Costa A, Kirkorian G, Cucherat M, et al. Antibiotic prophylaxis for permanent pacemaker implantation: a meta-analysis. Circulation. 1998;97(18):1796–801.PubMed Da Costa A, Kirkorian G, Cucherat M, et al. Antibiotic prophylaxis for permanent pacemaker implantation: a meta-analysis. Circulation. 1998;97(18):1796–801.PubMed
44.
go back to reference del Rio A, Anguera I, Miro JM, et al. Surgical treatment of pacemaker and defibrillator lead endocarditis: the impact of electrode lead extraction on outcome. Chest. 2003;124(4):1451–9.PubMedCrossRef del Rio A, Anguera I, Miro JM, et al. Surgical treatment of pacemaker and defibrillator lead endocarditis: the impact of electrode lead extraction on outcome. Chest. 2003;124(4):1451–9.PubMedCrossRef
45.
go back to reference Klug D, Lacroix D, Savoye C, et al. Systemic infection related to endocarditis on pacemaker leads: clinical presentation and management. Circulation. 1997;95(8):2098–107.PubMed Klug D, Lacroix D, Savoye C, et al. Systemic infection related to endocarditis on pacemaker leads: clinical presentation and management. Circulation. 1997;95(8):2098–107.PubMed
46.
go back to reference Santucci PA, Haw J, Trohman RG, Pinski SL. Interference with an implantable defibrillator by an electronic antitheft-surveillance device. N Engl J Med. 1998;339(19):1371–4.PubMedCrossRef Santucci PA, Haw J, Trohman RG, Pinski SL. Interference with an implantable defibrillator by an electronic antitheft-surveillance device. N Engl J Med. 1998;339(19):1371–4.PubMedCrossRef
47.
go back to reference Link MS, Estes NA 3rd, Griffin JJ, et al. Complications of dual chamber pacemaker implantation in the elderly. Pacemaker Selection in the Elderly (PASE) Investigators. Journal of Interventional Cardiac Electrophysiology. 1998;2(2):175–9.PubMedCrossRef Link MS, Estes NA 3rd, Griffin JJ, et al. Complications of dual chamber pacemaker implantation in the elderly. Pacemaker Selection in the Elderly (PASE) Investigators. Journal of Interventional Cardiac Electrophysiology. 1998;2(2):175–9.PubMedCrossRef
Metadata
Title
Cardiac Device Implantation in the United States from 1997 through 2004: A Population-based Analysis
Authors
Chunliu Zhan, MD, PhD
William B. Baine, MD
Artyom Sedrakyan, MD, PhD
Claudia Steiner, MPH, MD
Publication date
01-01-2008
Publisher
Springer-Verlag
Published in
Journal of General Internal Medicine / Issue Special Issue 1/2008
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-007-0392-0

Other articles of this Special Issue 1/2008

Journal of General Internal Medicine 1/2008 Go to the issue